ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Cost-Effectiveness"

  • Abstract Number: 0135 • ACR Convergence 2021

    Comparing Rheumatoid Arthritis (RA), Psoriatic Arthritis (PA) and Systemic Lupus Erythematosus (SLE) Total Cost of Care (TCC) in Those with Optimally Managed Depression to Those with Sub-optimally Managed Depression

    Joseph Couto1, Elisea Avalos-Reyes2, Amanda McCarthy3, Olga Matlin4, Michele Hamburger5, Gerard Maher6 and Kjel Johnson1, 1CVS Health, Lincoln, RI, 2CVS Health, Irving, TX, 3CVS Health, Greensboro, GA, 4CVS Health, Northbrook, IL, 5Frances Hamburger Institute, Hauppauge, NY, 6Frances Hamburger Institute, Hauppaugue, NY

    Background/Purpose: Rheumatic diseases (RD) are characterized by systemic signs and symptoms, including articular and extra-articular manifestations. Three common forms of RDs are RA, PsA and…
  • Abstract Number: 0143 • ACR Convergence 2021

    Economic and Healthcare Resource Use Burden of Systemic Sclerosis

    Dinesh Khanna1, Dan Furst2, Justin Li3, Qian Meng4, Tamara Lesperance5, Kenyatta Peoples6, Farah Ali5, Brian LaMoreaux5 and Stephanie Taylor7, 1University of Michigan, Ann Arbor, MI, 2University of California Los Angeles, Los Angeles, CA, 3Trinity Partners, Waltham, MA, 4Trinity Life Sciences, Waltham, MA, 5Horizon Therapeutics plc, Deerfield, IL, 6Horizon Therapeutics plc, Lake Forest, IL, 7Horizon Therapeutics plc, Whitehouse Station, NJ

    Background/Purpose: The clinical burden of systemic sclerosis (SSc) is substantial and typically characterized by progressive skin, gastrointestinal, pulmonary, and cardiovascular complications and premature death. The…
  • Abstract Number: 0228 • ACR Convergence 2021

    Optimizing Social Media as a Recruitment Tool for Hard-to-Reach Populations in Rheumatology Clinical Research

    Vladislav Tsaltskan1, Katherine Nguyen1, Christina Eaglin1, Kevin Deane2, V. Michael Holers3 and Gary Firestein1, 1University of California San Diego, San Diego, CA, 2University of Colorado Denver, Denver, CO, 3University of Colorado, Denver, CO

    Background/Purpose: Standard methods of recruitment for clinical research, such as traditional media advertisements, can be inefficient and expensive, especially for underserved communities and asymptomatic individuals.…
  • Abstract Number: 0465 • ACR Convergence 2021

    Cost-effectiveness of Treatment Strategies Involving Arthroscopic Partial Meniscectomy and Physical Therapy for Degenerative Meniscal Tear

    Emma Williams1, Valia Leifer1, Jamie Collins2, Tuhina Neogi3, Lisa Suter4, Jeffrey Katz5 and Elena Losina2, 1The Orthopaedic and Arthritis Center for Outcomes Research (OrACORe) at Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Boston University School of Medicine, Boston, MA, 4Yale School of Medicine, New Haven, CT, 5Brigham and Women's Hospital, Brookline, MA

    Background/Purpose: Knee osteoarthritis (KOA) and meniscal tear (MT) are highly prevalent and often concomitant. Treatments for MT in the presence of KOA include physical therapy…
  • Abstract Number: 1056 • ACR Convergence 2021

    Characterization of the Patterns of Care, Access and Direct Costs of Systemic Lupus Erythematosus in Brazil: Findings from the Macunaíma Study

    Mirhelen Mendes de Abreu1, Vander Fernandes2, Odirlei Andre Monticielo3, Alexandre Cristovão Maiorano1, Fernando dos Santos Beserra1, Flavia Rachel Moreira Lamarão4, Nathalie David4, Bruna de Veras4, Magda Araujo4, Blanca Elena Rios Gomes Bica5, Dalianna Luise Andrade Souto Rodrigues2, Guilherme Andrade Bulbol6, Natalia Jardim Martins da Silva7, Domingos Sávio Nunes de Lima6 and Marta Maria das Chagas Medeiros7, 1Faculdade de Medicina, Universidade Federal do Rio de Janeiro; MAPEAR Laboratory, Universidade Federal do Rio de Janeiro, Rio De Janeiro, Brazil, 2Universidade de Cuiabá, Cuiabá, Brazil, 3Serviço de Reumatologia do Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, 4GlaxoSmithKline, Medical Department, Rio de Janeiro, Brazil, 5Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil, 6Hospital Universitário Getúlio Vargas, Universidade Federal do Amazonas, Manaus, Brazil, 7Faculdade de Medicina, Universidade Federal do Ceará, Fortaleza, Brazil

    Background/Purpose: This study evaluated the patterns of care, access and direct costs related to the management and treatment of patients with systemic lupus erythematosus (SLE)…
  • Abstract Number: 1129 • ACR Convergence 2021

    Cost-effectiveness of Weight Loss Interventions Prior to Total Knee Replacement for Patients with Advanced Knee Osteoarthritis and Class III Obesity

    Aleksandra Kostic1, Valia Leifer2, Tuhina Neogi3, David Hunter4, Lisa Suter5, Faith Selzer6, Jeffrey Katz1 and Elena Losina7, 1Brigham and Women's Hospital, Brookline, MA, 2The Orthopaedic and Arthritis Center for Outcomes Research (OrACORe) at Brigham and Women's Hospital, Boston, MA, 3Boston University School of Medicine, Boston, MA, 4Institute of Bone and Joint Research, University of Sydney, St Leonards, Australia, 5Yale School of Medicine, New Haven, CT, 6Brigham and Women's Hospital, Amesbury, MA, 7Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Class III obesity, defined by BMI >40kg/m2, is linked to increased risk of complications post total knee replacement (TKR). This has led to recommendations…
  • Abstract Number: 1269 • ACR Convergence 2021

    The Burden of Systemic Lupus Erythematosus Patients in the United States – Evidence from the Medical Expenditure Panel Survey (2016-2018)

    Shannon Grabich1, Eilleen Farrelly2, Robert Ortmann3, Michael Pollack4 and Sandra Sze-jung Wu4, 1Xcenda, Durham, NC, 2Xcenda, Carrollton, TX, 3AstraZeneca, Greenwood, IN, 4AstraZeneca, Wilmington, DE

    Background/Purpose: Due to the heterogeneity of systemic lupus erythematosus (SLE), clinical characteristics, quality of life (QOL), social determinant of health (SDOH), health care utilization (HRU),…
  • Abstract Number: 0478 • ACR Convergence 2020

    Increasing Awareness of Advocacy During Early Career – a Web-Based Educational Program

    Sirisha Gokaraju1, Angus Worthing2, Katherine Maher3, Grace Wright4 and Gail Kerr5, 1Georgetown University hospital, Bethesda, MD, 2Arthritis & Rheumatism Associates, PC, Washington, DC, 3Arthritis & Rheumatism Associates, PC, Alexandria, VA, 4Association of Women in Rheumatology, New York, NY, 5Washington DC VA Medical Center, Washington, DC

    Background/Purpose: In 2015, the American College of Rheumatology (ACR) began Advocacy 101 in person-education for Fellows in Training (FIT) and physicians to encourage participation in…
  • Abstract Number: 0567 • ACR Convergence 2020

    Rheumatologist’s Perception of the Efficacy, Safety and Willingness to Prescribe Infliximab and Use Alternate Drug Supply Programs to Lower Cost of Rheumatoid Arthritis Care

    Cesar Galan1, Alan Puric2, Guy Cozzi2, Michele Hamburger3, Elisea Avalos-Reyes4 and Kjel Johnson1, 1CVS Health, Lincoln, RI, 2CVS Health, Northbrook, IL, 3Frances Hamburger Institute, Hauppauge, NY, 4CVS Health, Irving, TX

    Background/Purpose: There is interest in employing biosimilar therapies for patients with rheumatoid arthritis (RA), which have been shown comparable to originator biologics in safety and…
  • Abstract Number: 0569 • ACR Convergence 2020

    Ability and Willingness to Utilize Telemedicine Among Rheumatology Patients – a Cross Sectional Survey

    Steve Kong1, Lilian Otalora Rojas2, Amnie Ashour3, Mathew Robinson1 and Neha Bhanusali1, 1University of Central Florida College of Medicine, Orlando, 2University of Central Florida HCA Healthcare GME, Orlando, 3Stony Brook University School of Medicine, New York

    Background/Purpose: Telemedicine (TM) is the delivery of health care services using information and communication technologies. TM presents unique opportunities and benefits specifically in rheumatology as…
  • Abstract Number: 0572 • ACR Convergence 2020

    Two-year Cost-effectiveness Between Two Gradual Tapering Strategies in Rheumatoid Arthritis: Cost-utility Analysis of the TARA Trial

    Elise van Mulligen1, Angelique Weel2, Mieke Hazes3, Annette van der Helm - van Mil4 and Pascal de Jong1, 1Erasmus MC, Rotterdam, Netherlands, 2Erasmus School of Health Policy & Management, Maasstad hospital, Erasmus MC, Rotterdam, Netherlands, 3Erasmus Medical Center, Rotterdam, Netherlands, 4Leiden University Medical Center, Erasmus Medical Center, Leiden, Netherlands

    Background/Purpose: The benefits of tapering are a decreased risk of long-term adverse events and a reduction of health care costs, especially when bDMARDs are tapered.…
  • Abstract Number: 0576 • ACR Convergence 2020

    Medical Savings of Timely Rheumatoid Arthritis Diagnoses

    Kathryn Johnson1, Christine Sawicki1, Cristina Sotelo2, Tanvi Kalevar3, Sylvie Lardeux4, Fabio Casadio3, David Baghdadi5, Michele Hamburger6, Elisea Avalos-Reyes7 and Kjel Johnson1, 1CVS Health, Lincoln, RI, 2CVS Health, Austin, TX, 3CVS Health, New York, NY, 4CVS Health, Wellesley, MA, 5CVS Health, Woonsocket, RI, 6Frances Hamburger Institute, Hauppauge, NY, 7CVS Health, Irving, TX

    Background/Purpose: Previous studies suggest that early rheumatoid arthritis (RA) recognition and treatment provides greater clinical benefits than treatment started later in the disease course. However,…
  • Abstract Number: 0579 • ACR Convergence 2020

    Risk Factors of Nonadherence in New Rheumatoid Arthritis Patients

    Guy Cozzi1, Pavlo Kyrychenko2, Michele Hamburger3 and Elisea Avalos-Reyes4, 1CVS Health, Northbrook, IL, 2CVS Health, Norhtbrook, IL, 3Frances Hamburger Institute, Hauppauge, NY, 4CVS Health, Irving, TX

    Background/Purpose: Biologic disease-modifying antirheumatic drug (bDMARD) therapies are commonly prescribed for rheumatoid arthritis (RA) treatment. However, their high out-of-pocket (OOP) cost may limit patient access…
  • Abstract Number: 0582 • ACR Convergence 2020

    Mortality and Cost of Hospitalization: Do Hospitals Caring for More SLE Patients Perform Better?

    Christine Anastasiou1, Laura Trupin1, Patricia Katz2, Zara Izadi3, Milena Gianfrancesco1, Gabriela Schmajuk4 and Jinoos Yazdany5, 1University of California, San Francisco, San Francisco, CA, 2University of California, San Francisco, Novato, CA, 3University of California San Francisco, San Francisco, CA, 4University of California, San Francisco, Atherton, CA, 5UCSF, San Francisco, CA

    Background/Purpose: Individuals with systemic lupus erythematosus (SLE) have an increased risk of hospitalization throughout their lifetime, potentially leading to higher patient mortality and healthcare costs.…
  • Abstract Number: 0583 • ACR Convergence 2020

    Cost of Illness in Patients with Psoriasis and Psoriatic Arthritis

    Santos Castañeda1, Esther Francisca Vicente-Rabaneda2, Mar Llamas-Velasco3, Javier Sánchez-Pérez3, José Pardo4, Rita Cabeza-Martínez5, Mercedes Miranda-Fontes6, Juan Márquez7, Jaime Calvo-Alén8, Susana Armesto9, Isabel Belinchón10, Alejandro Gómez11, María Dolores Miranda12, Silvia Martínez-Pardo13, Leticia Merino Melendez14, Miguel Ángel Casado15, María Yébenes15 and Araceli Casado15, 1Princesa University Hospital, Universidad Autónoma, Madrid, Madrid, Spain, 2Hospital Universitario de la Princesa, IIS-Princesa, UAM, Madrid, Madrid, Spain, 3Hospital Universitario de la Princesa, IIS-Princesa, Madrid, Madrid, Spain, 4H.G.U. Santa Lucía, Cartagena, Murcia, Spain, 5H.U. Puerta de Hierro Majadahonda, Madrid, Madrid, Spain, 6H.U. Río Hortega, Valladolid, Valladolid, Castilla y Leon, Spain, 7H.G. Jerez de la Frontera, Cádiz, Andalucia, Spain, 8Hospital Universitario Araba, Vitoria-Gasteiz, Pais Vasco, Spain, 9H.U. Marqués de Valdecilla, Santander, Cantabria, Spain, 10H.G.U. Alicante, Alicante, Comunidad Valenciana, Spain, 11H.U. Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain, 12H.G. San Agustín de Linares, Jaen, Andalucia, Spain, 13H. Mutua de Terrassa, Barcelona, Catalonia, Spain, 14H. San Pedro, Logroño, Spain, 15Pharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, Madrid, Spain

    Background/Purpose: Psoriasis (Ps) and psoriatic arthritis (PsA) have a major impact on patients’ health-related quality of life. Cost of illness of patients with Ps, PsA and…
  • 1
  • 2
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies